March 01, 2021 Go or no go? A delayed decision on Evrenzo March will see big US decisions for Evrenzo and ide-cel, while tanezumab goes in front of an advisory committee.
October 08, 2018 US opioid crisis package nears enactment Medicare is to review ways to encourage use of non-addictive pain relievers, but Heron Therapeutics will miss out on extension of a special payment provision.